Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Leinco Technologies Inc Anti-Mouse CD90.2 (Thy-1.2) In Vivo PLATINUM; Clone 30-H12; Isotype: Rat IgG2b κ
SDP

Supplier:  Leinco Technologies Inc C4305.0 MG

Encompass_Preferred

Specificity: Clone 30-H12 recognizes mouse CD90.2. Antigen Distribution: CD90.2 is present on hematopoietic stem cells and neurons, all thymocytes, peripheral T cells of the Thy-1.2 bearing mice.Background: CD90.2 is a 25-35 kD in the Ig superfamily and is a GPI-anchored membrane glycoprotein involved in signal transduction. It interacts with CD45. It is involved in costimulation of lymphocyte proliferation and induction of hematopoietic stem cells differentiation. Applications: (IP, WB) 30-H12 may induce Ca2+ flux in thymocytes and, in combo with anti- CD3/TCR complex, promote thymocyte apoptosis and inhibit CD3-mediated proliferative responses of mature T lymphocytes. Leinco’s In vivo GOLDTM and In vivo PLATINUMTM functional antibodies are manufactured in an animal free facility using only In vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.

Catalog No. 50-190-6154


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.